Equities

China Traditional Chinese Medicine Holdings Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

China Traditional Chinese Medicine Holdings Co Ltd

Actions
  • Price (EUR)0.212
  • Today's Change-0.002 / -0.93%
  • Shares traded0.00
  • 1 Year change-7.83%
  • Beta0.6309
Data delayed at least 15 minutes, as of Feb 06 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

China Traditional Chinese Medicine Holdings Co Ltd is an investment holding company mainly engaged in the traditional Chinese medicines (TCM) business. The Company operates its business through four segments. Yi Fang segment mainly manufactures and sales of concentrated TCM granules (CTCMG), TCM healthcare products, and TCM decoction pieces. Tian Jiang segment mainly manufactures and sales of CTCMG, TCM decoction pieces, and TCM healthcare products. The segment also provides Chinese medical related healthcare solutions, including Chinese medical consultation and diagnosis, TCM physiotherapy, and prescription with CTCMG and others, through its offline medical institutions. Tong Ji Tang segment mainly manufactures and sales of CTCMG, TCM decoction pieces and TCM finished drugs. The segment also manufactures and sales of healthcare products in great health industry. Medi-World segment mainly manufactures and sales of TCM finished drugs and provision of TCM Healthcare Solutions.

  • Revenue in HKD (TTM)17.54bn
  • Net income in HKD-298.05m
  • Incorporated1992
  • Employees15.58k
  • Location
    China Traditional Chinese Medicine Holdings Co LtdRoom 1601, Emperor Group Centre288 Hennessy RoadWanchai Hong KongHKG
  • Phone+852 28543393
  • Fax+852 25441269
  • Websitehttps://www.china-tcm.com.cn/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.